他克莫司
医学
糖尿病酮症酸中毒
钙调神经磷酸酶
免疫抑制
急性胰腺炎
胰腺炎
糖尿病
器官移植
移植
内科学
胰腺移植
肾移植
肾
胃肠病学
内分泌学
作者
Mastakim Ahmed Mazumder,Sanjeev Gulati,AS Narula,Durre Shehwar,Ishrat Majid Mir
摘要
Calcineurin inhibitors (CNIs) are often associated with abnormalities in glucose and lipid metabolism. Tacrolimus is the most potent CNI which is nowadays used almost universally as a part of triple-drug immunosuppression after kidney transplantation. Tacrolimus can cause islet cell damage and decrease in insulin secretion which can lead to post-transplant diabetes mellitus and rarely diabetic ketoacidosis. Although rare, acute pancreatitis has also been implicated by a few case reports to be associated with tacrolimus. However, tacrolimus-induced acute pancreatitis has not been reported in pediatric kidney transplant recipient till date.We report the first case of tacrolimus-induced acute pancreatitis in association with hypertriglyceridemia and DKA in a child early after kidney transplant. The patient was managed with supportive treatment, and tacrolimus was stopped for three days and then switched to cyclosporine-based regimen. The patient became euglycemic within 8 weeks of switching to cyclosporine and did not have any recurrence of pancreatitis.Tacrolimus-induced pancreatitis is rare in the setting of kidney transplants and prompt diagnosis and management can lead to a successful outcome.
科研通智能强力驱动
Strongly Powered by AbleSci AI